Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2021

Dec 1, 2021

30442_dirs_2021-12-01_014517bb-7c40-4547-bc65-daa173dd897b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-11-29

Reporting Person: Medpace Investors, LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-29 Common Stock S 12115 $212.10 Disposed 5841253 Direct
2021-11-30 Common Stock S 197 $210.29 Disposed 5841056 Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.